Your browser doesn't support javascript.
loading
Which basal insulin should be used in patients with type 2 diabetes mellitus?
Clore, John N; Thurby-Hay, Linda.
Afiliación
  • Clore JN; Division of Endocrinology and Metabolism, Virginia Commonwealth University, North Hospital, 1300 E. Marshall Street, Richmond, VA 23298, USA. jclore@mcvh-vcu.edu
Curr Diab Rep ; 7(5): 348-52, 2007 Oct.
Article en En | MEDLINE | ID: mdl-18173967
The initiation of insulin therapy is a significant event for patients with diabetes and the physicians who care for them. Reluctance to begin insulin is multifactorial, with major stumbling blocks being the perceived complexity of insulin and fear of hypoglycemia. Recent guidelines supporting earlier introduction of insulin to achieve glycemic goals in patients with type 2 diabetes mellitus will require that traditional approaches to insulin therapy be altered and a new paradigm be introduced into clinical practice. In particular, an understanding of the role of basal insulin in the regulation of glucose and the development of strategies to implement basal insulin therapy can provide a transition that is rational and highly effective in most patients. The strategy also offers a unique approach to diabetes education that permits a focused and patient-specific correction to glucose abnormalities.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insulina Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Curr Diab Rep Asunto de la revista: ENDOCRINOLOGIA Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insulina Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Curr Diab Rep Asunto de la revista: ENDOCRINOLOGIA Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos